Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Orforglipron, the first oral GLP-1 receptor agonist to reach approval, was cleared by the FDA on 1 April 2026 as Foundayo for chronic weight management, based on the ATTAIN-1 and ATTAIN-2 trials (72-week mean weight loss of approximately 12% at the highest dose)
For a 5mg vial where you might draw 10-20 individual doses, using sterile water would waste the vast majority of your peptide
Accurate dosing ensures consistent results across treatment cycles
AHK-Cu 50mg $50.00 In stock In stock AHK-Cu (Copper Tripeptide-3) AHK-Cu (Copper Tripeptide-3) is a synthetic copper-binding tripeptide composed of alanine, histidine, and lysine complexed with a copper ion
This makes walking a difficult task for the afflicted patient
Despite their popularity, its crucial to approach these treatments with informed caution, considering the varying degrees of scientific support and the importance of professional medical guidance
US$ 21.35
US$ 23.59
US$ 27.97
